s6y

AIBOTICS THERAPIES, INC.

Ticker
AIBT
CIK
1763329
Industry
Medicinal Chemicals & Botanical Products
Formerly
AIBOTICS, INC., Mycotopia Therapies, Inc., 20/20 Global, Inc.

Financials 56

  1. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Jun 30, 2026
  4. 10-Q Quarterly Report for period ending Mar 31, 2026
  5. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Mar 31, 2026
  6. 10-K Annual Report for period ending Dec 31, 2025
  7. NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending Dec 31, 2025
  8. 10-Q Quarterly Report for period ending Sep 30, 2025
  9. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Sep 30, 2025
  10. 10-Q Quarterly Report for period ending Jun 30, 2025

All 56 financials filings

News 17

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 17 news filings

Ownership 7

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 3 Initial statement of beneficial ownership of securities
  7. 3 Initial statement of beneficial ownership of securities

Prospectus 9

  1. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  2. 1-A/A Offering statement under Regulation A
  3. 1-A/A Offering statement under Regulation A
  4. 1-A/A Offering statement under Regulation A
  5. 1-A/A Offering statement under Regulation A
  6. 1-A Offering statement under Regulation A
  7. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  8. 1-A Offering statement under Regulation A
  9. RW Registration Withdrawal Request

Proxies 2

  1. DEF 14C Definitive information statements
  2. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition

Other 21

  1. SCHEDULE 13G
  2. 253G2 Reflects information that constitutes a substantive change from or addition to the information set forth in the last offering circular
  3. QUALIF
  4. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  5. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  6. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  7. UPLOAD Letter (PDF)
  8. UPLOAD Letter (PDF)
  9. QUALIF
  10. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

All 21 other filings